248 related articles for article (PubMed ID: 8672735)
21. Chronic inhibition of nitric oxide ameliorates splanchnic hyposensitivity to glypressin in a hemorrhage-transfused rat model of portal hypertension.
Huang HC; Chu CJ; Lee FY; Chang FY; Wang SS; Lin HC; Hou MC; Chan CC; Wu SL; Chen CT; Lee SD
Scand J Gastroenterol; 2000 Dec; 35(12):1308-13. PubMed ID: 11199372
[TBL] [Abstract][Full Text] [Related]
22. Effect of verapamil on nitric oxide synthase in a portal vein-ligated rat model: role of prostaglandin.
Lay CS; May CM; Lee FY; Tsai YT; Lee SD; Chien S; Sinchon S
World J Gastroenterol; 2006 Apr; 12(15):2351-6. PubMed ID: 16688824
[TBL] [Abstract][Full Text] [Related]
23. Modulation of the hyperdynamic circulation of cirrhotic rats by nitric oxide inhibition.
Pizcueta P; Piqué JM; Fernández M; Bosch J; Rodés J; Whittle BJ; Moncada S
Gastroenterology; 1992 Dec; 103(6):1909-15. PubMed ID: 1451984
[TBL] [Abstract][Full Text] [Related]
24. [Hemodynamic effects of sub-chronic NO synthase inhibition in conscious dogs: role of EDRF/NO in muscular exertion].
Puybasset L; Béa ML; Simon L; Ghaleh B; Giudicelli JF; Berdeaux A
Arch Mal Coeur Vaiss; 1995 Aug; 88(8):1217-21. PubMed ID: 8572877
[TBL] [Abstract][Full Text] [Related]
25. Evidence for normal nitric oxide-mediated vasodilator tone in conscious rats with cirrhosis.
Sogni P; Moreau R; Ohsuga M; Cailmail S; Oberti F; Hadengue A; Pussard E; Lebrec D
Hepatology; 1992 Oct; 16(4):980-3. PubMed ID: 1328013
[TBL] [Abstract][Full Text] [Related]
26. Acute haemodynamic effects of losartan in anaesthetized cirrhotic rats.
Heller J; Shiozawa T; Trebicka J; Hennenberg M; Schepke M; Neef M; Sauerbruch T
Eur J Clin Invest; 2003 Nov; 33(11):1006-12. PubMed ID: 14636305
[TBL] [Abstract][Full Text] [Related]
27. Hemodynamic effects of dopamine in conscious rats with secondary biliary cirrhosis.
Bacq Y; Roulot D; Braillon A; Lebrec D
J Hepatol; 1990 Sep; 11(2):257-62. PubMed ID: 2254634
[TBL] [Abstract][Full Text] [Related]
28. Vasopressin response and shunting modulation in cirrhotic rats by chronic nitric oxide inhibition.
Huang HC; Wang SS; Lee FY; Chang CC; Chang FY; Lin HC; Hou MC; Lee SD
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e265-9. PubMed ID: 17764528
[TBL] [Abstract][Full Text] [Related]
29. Increased blood hemoglobin attenuates splanchnic vasodilation in portal-hypertensive rats by nitric oxide inactivation.
Casadevall M; Piqué JM; Cirera I; Goldin E; Elizalde I; Panés J; Martínez-Cuesta MA; Bosch J; Terés J; Rodés J
Gastroenterology; 1996 Apr; 110(4):1156-65. PubMed ID: 8613005
[TBL] [Abstract][Full Text] [Related]
30. NO overproduction by eNOS precedes hyperdynamic splanchnic circulation in portal hypertensive rats.
Wiest R; Shah V; Sessa WC; Groszmann RJ
Am J Physiol; 1999 Apr; 276(4):G1043-51. PubMed ID: 10198349
[TBL] [Abstract][Full Text] [Related]
31. [The effect of PGI2 on formation and development of hyperdynamic circulatory state in portal hypertensive rats].
Wu ZY; Chen XS; Cao H
Zhonghua Wai Ke Za Zhi; 2003 Jul; 41(7):537-40. PubMed ID: 12921664
[TBL] [Abstract][Full Text] [Related]
32. Role of prostacyclin in hemodynamic alterations in conscious rats with extrahepatic or intrahepatic portal hypertension.
Oberti F; Sogni P; Cailmail S; Moreau R; Pipy B; Lebrec D
Hepatology; 1993 Sep; 18(3):621-7. PubMed ID: 8359803
[TBL] [Abstract][Full Text] [Related]
33. Effects of tumor necrosis factor, endothelin and nitric oxide on hyperdynamic circulation of rats with acute and chronic portal hypertension.
Wang JJ; Gao GW; Gao RZ; Liu CA; Ding X; Yao ZX
World J Gastroenterol; 2004 Mar; 10(5):689-93. PubMed ID: 14991939
[TBL] [Abstract][Full Text] [Related]
34. Nebivolol treatment increases splanchnic blood flow and portal pressure in cirrhotic rats via modulation of nitric oxide signalling.
Reiberger T; Payer BA; Schwabl P; Hayden H; Horvatits T; Jäger B; Hummel T; Mitterhauser M; Trauner M; Fuhrmann V; Angermayr B; Peck-Radosavljevic M;
Liver Int; 2013 Apr; 33(4):561-8. PubMed ID: 23331709
[TBL] [Abstract][Full Text] [Related]
35. Hyporeactivity of mesenteric resistance arteries in portal hypertensive rats.
Sogni P; Sabry S; Moreau R; Gadano A; Lebrec D; Dinh-Xuan AT
J Hepatol; 1996 Apr; 24(4):487-90. PubMed ID: 8738736
[TBL] [Abstract][Full Text] [Related]
36. Role of EDRF in splanchnic blood flow of normal and chronic portal hypertensive rats.
Iwata F; Joh T; Kawai T; Itoh M
Am J Physiol; 1992 Aug; 263(2 Pt 1):G149-54. PubMed ID: 1514624
[TBL] [Abstract][Full Text] [Related]
37. Effects of nitric oxide inhibitor on prostacyclin biosynthesis in portal hypertensive rats.
Cao H; Wu Z; Zhou J; Chen Z; Kuang Y
Chin Med J (Engl); 1999 Jun; 112(6):516-9. PubMed ID: 11601330
[TBL] [Abstract][Full Text] [Related]
38. Vascular nitric oxide production during the development of two experimental models of portal hypertension.
Gadano AC; Sogni P; Heller J; Moreau R; Bories PN; Lebrec D
J Hepatol; 1999 May; 30(5):896-903. PubMed ID: 10365818
[TBL] [Abstract][Full Text] [Related]
39. Acute and chronic cyclooxygenase blockage in portal-hypertensive rats: influence in nitric oxide biosynthesis.
Fernández M; García-Pagán JC; Casadevall M; Mourelle MI; Piqué JM; Bosch J; Rodés J
Gastroenterology; 1996 May; 110(5):1529-35. PubMed ID: 8613060
[TBL] [Abstract][Full Text] [Related]
40. Pravastatin administration does not induce detrimental effects on hemodynamics and collaterals of portal hypertensive rats.
Chang CC; Wang SS; Huang HC; Lee JY; Lee FY; Lin HC; Lee SD
J Gastroenterol Hepatol; 2010 Aug; 25(8):1394-400. PubMed ID: 20659229
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]